Left ventricular hypertrophy and endothelial functions in patients with essential hypertension

Coronary Artery Disease

Volumn 14, Issue 8, 2003, Pages 541-544

  Ercan, Ertugrul ^a   Tengiz, Istemihan ^a   Ercan, H Ekin ^a   Nalbantgil, Istemi ^b  

^a Central Hospital   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Endothelium; Flow mediated dilatation; Hypertension; Left ventricular hypertrophy

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; EXERCISE TEST; FEMALE; FLOW MEASUREMENT; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR ENDOTHELIUM;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY SURFACE AREA; BRACHIAL ARTERY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY CIRCULATION; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; TRIGLYCERIDES; VASODILATION;

EID: 4344570321     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200312000-00004     Document Type: Article

References (31)

1. Gimbrone MA Jr. Vascular endothelium in health and disease. In: Haber E (editors), Molecular cardiovascular medicine. Chapter 4. New York: Scientific American Medicine; 1995. pp. 49-61.
2. Simionescu N, Simionescu M. Endothelial cell dysfunctions. New York: Plenum Press; 1992. p. 17.
3. Celemajer DS, Soronsen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
4. Ercan E, Ceyhan C, Gurgun C, et al. The effects of cholesterol lowering therapy with atorvastatin on flow-mediated vasodilatation in patients with hypercholesterolaemic coronary artery disease. Polish Heart J 2001; 55:503-506.
5. Ravikumar R, Deepa R, Shanthirani C, et al. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and non-diabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002; 90:702-707.
6. Dalli E, Segarra L, Ruvira J, et al. Brachial artery flow-mediated dilation in healthy men, men with risk factors, and men with acute myocardial infarction. Importance of occlusion-cuff position. Rev Esp Cardiol 2002; 55:928-935.
7. Lee IK, Kim HS, Bae JH. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidaemia. Int J Clin Pract Suppl 2002; 129:59-64.
8. Furumoto T, Saito N, Dong J, et al. Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: implications for early atherosclerosis. Hypertens Res 2002; 25:475-480.
9. Dunn FG, Pfeffer MA. Left ventricular hypertrophy in hypertension. N Engl J Med 1999; 340:1279-1280.
10. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol 1979; 44:959-963.
11. Devereux RB, de Simone G, Ganau A, Roman MJ. Pathogenesis of left ventricular hypertrophy. Cardiovasc Risk Factors 1995; 5:109-120.
12. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90:2622-2628.
13. Schunkert H, Hense HW, Holmer S, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330:1634-1638.
14. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ. Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994; 267:1107-1111.
15. Ganau A, Devereux RB, Pickering TG, et al. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation 1990; 81:25-36.
16. Celenteno A, Mancini FP, Crivaro M, et al. Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol 1999; 83:1196-1200.
17. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97:48-54.
18. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
19. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
20. Muiesan ML, Salvetti M, Monteduro C, et al. Flow-mediated dilatation of the brachial artery and left ventricular geometry in hypertensive patients. J Hypertens 2001; 19:641-647.
21. Sung J, Ouyang P, Bacher AC, et al. Peripheral endothelium-dependent flow-mediated vasodilatation is associated with left ventricular mass in older persons with hypertension. Am Heart J 2002; 144:39-44.
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M- mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
23. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
24. Savage DD, Levy D, Dannenberg AL, Garrison RJ, Castelli WP. Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (The Framingham Study). Am J Cardiol 1990; 65:371-376.
25. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59:956-960.
26. Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 1995; 76:699-701.
27. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39:257-265.
28. Jiang L, Shui-Ping Z, Xiang Ping L, et al. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61:165-169.
29. Cardillo C, Kilcoyne CM, Quyyumi AA, Cannon RO, Panza JA. Selective defect in nitric oxide synthesis may explain the impaired endothelium dependent vasodilation in patients with essential hypertension. Circulation 1988; 97:851-856.
30. Panza JA, Casino PR, Kilcoyne MC, Quyyumi AA. Role of endothelium derived nitric oxide in the abnormal endothelium dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87:1468-1474.
31. Iiyama K, Nagano M, Yo Y, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996; 132:779-782.